25 research outputs found

    One-Dimensional Convolutional Neural Network for Pipe Jacking EPB TBM Cutter Wear Prediction

    Get PDF
    An earth pressure balance (EPB) TBM is used in soft ground conditions, and these conditions lead to the fluctuation and instability of machine parameters. Machine parameters influence cutter wear and tunnel excavation. For this reason, to evaluate and predict the cutter wear of an EPB TBM, a 1D CNN model was used to provide machine-parameter-based cutter wear prediction using an EPB TBM operational dataset. The machine parameters were split into 80% training and 20% test datasets. Compared to traditional machine learning applications and two deep neural network models, the proposed model provided reliable results with a reasonable computational time. The correlation coefficient was 89.6% R-2, the mean squared error (MSE) was 57.6, the mean absolute error (MAE) was 1.6, and the computational wall time was 3 min 22 s

    One-Dimensional Convolutional Neural Network for Pipe Jacking EPB TBM Cutter Wear Prediction

    No full text
    An earth pressure balance (EPB) TBM is used in soft ground conditions, and these conditions lead to the fluctuation and instability of machine parameters. Machine parameters influence cutter wear and tunnel excavation. For this reason, to evaluate and predict the cutter wear of an EPB TBM, a 1D CNN model was used to provide machine-parameter-based cutter wear prediction using an EPB TBM operational dataset. The machine parameters were split into 80% training and 20% test datasets. Compared to traditional machine learning applications and two deep neural network models, the proposed model provided reliable results with a reasonable computational time. The correlation coefficient was 89.6% R-2, the mean squared error (MSE) was 57.6, the mean absolute error (MAE) was 1.6, and the computational wall time was 3 min 22 s

    Prospective Randomized Trial to Determine Whether Inhalational Anesthetics Have Any Effects on Hearing Function

    No full text
    WOS: 000273634500012PubMed: 19755091Objective: The purpose of this study was to investigate and compare the effects of inhalation anesthetics (sevoflurane and isoflurane) on hearing function by using an audiometric test battery. Design: A prospective, randomized, double-blind, clinical trial. Setting: University hospital. Patients: Fifty-three adult patients (American Society of Anesthesiologists I-II) scheduled for sinonasal surgery with intratracheal general anesthesia were enrolled in the study. The patients were premedicated with diazepam intramuscularly. Propofol 2 mg/kg (Diprivan, AstraZeneca, Wilmington, DE) was given intravenously (IV) for induction of general anesthesia. After endotracheal intubation with vecuronium IV (1 mg/kg), in group 1 (n = 27) sevoflurane 2% and in group 2 (n = 26) isoflurane 1.2% were used to maintain general anesthesia. All patients received nitrous oxide during maintenance. Main Outcome Measures: The patients' hearing function was measured before anesthesia and 24 hours after surgery by means of pure-tone audiometry, high-frequency pure-tone audiometry, and transient evoked otoacoustic emissions (TEOAEs) by the same clinician. Results: There were no statistically significant differences between the demographic data and the hemodynamic and respiratory parameters of the groups. No significant differences were found between groups in hearing thresholds of conventional pure-tone audiometry and extended high frequency (p > .05). For TEOAE responses, no statistically significant differences were determined between pre- and postoperative measurements (p > .05). Conclusion: It was audiometrically demonstrated that general anesthesia did not affect the hearing function in any of the patients undergoing sinonasal surgery. These findings encourage the use of sevoflurane or isoflurane as a safe agent without any ototoxic effects in otorhinolaryngologic surgery with general anesthesia

    The Role of Platelet-Derived Growth Factor in the Pathogenesis of Sinonasal Polyps: Immunohistochemical Assessment in Epithelial, Subepithelial and Deep Layers of the Mucosa

    Get PDF
    WOS: 000325040300006PubMed: 24069518Objectives:The aim of this study is to investigate the role of platelet-derived growth factor (PDGF) in the pathogenesis of sinonasal polyps. Methods. Study group (groups 1-3) consisted of nasal polyp samples of patients with sinonasal polyps and the control group consisted of inferior turbinate samples of patients without nasal polyp. In group 1, 14 specimens from ethmoid sinus; in group 2,10 specimens from nasal cavity; in group 3,10 specimens from maxillary sinus; and in group 4 (control), 9 specimens from inferior turbinate were included. By immunohistochemical staining technique, the PDGF positivity index (PI) in mucosal layers and in the inflammatory cells were assessed at the epithelium (EP), subepithelial layer of lamina propria (SE), and deep paraglandular layer of the mucosa (D). Results. Polymorphonudear cell (PMNC)-percentage (%) values of ethmoid and maxillary sinus, and the PDGF PI from all cells of ethmoid sinus and nasal cavity were significantly higher than those of the control group. As mononuclear cell-% (MNC-%) increased, the PDGF_EP_basal PI, PDGF_SE_endothelial PI, and PDGF_D_endothelial PI decreased. As PMNC-PDGF PI increased, the PDGF_D_perivascular PI decreased and PDGF_D_endothelial PI increased. As PDGF-MNC PI increased, the PDGF_EP_apical PI, PDGF_SE_endothelial PI, and PDGF_D_endothelial PI decreased. As PDGF-all cells (PMNCs, MNCs, and fibroblasts) PI increased, the PDGF_EP_basal PI and PDGF_D_endothelial PI decreased, and the PDGF_D_perivascular PI increased. Conclusion. We concluded that the PDGF systems play important roles in polyp pathogenesis. Fibroblast-derived PDGF may be more important than MNC-derived PDGF in polyp developing process. Increased perivascular-PDGF-PI in deep layers of the mucosa may result in sinonasal polyp formation by causing an increase in vascular permeability and extracellular edema, and thus promoting migration of inflammatory cells to extracellular area. Tissue oxygenization may be important for the initiation of PDGF release system. Because of this reason, nasal obstruction should be medically treated earlier, and, if necessary, by surgical approaches.Kirikkale University Scientific Research Projects Unit FundsKirikkale UniversityThis study was supported by "Kirikkale University Scientific Research Projects Unit Funds.

    High-Dose Ropivacaine versus Bupivacaine for Posttonsillectomy Pain Relief in Adults

    No full text
    WOS: 000207463500026PubMed: 19128713Objective: To compare the efficacy and safety of preincisional high-dose ropivacaine with bupivacaine in relieving posttonsillectomy pain. Design: A prospective, randomized, double blind, placebo-controlled clinical trial. Setting: University hospital. Patients: Before the incision, 58 subjects were randomly assigned to receive 10 mL of 10 mg/mL ropivacaine hydrochloride with epinephrine (n = 19, group 1), 10 mL of 2.5 mg/mL bupivacaine with epinephrine (n = 20, group 2), or saline with epinephrine (n = 19, group 3) as a placebo. Main Outcomes Measures: Postoperative pain, additional analgesic drug consumption, otalgia, operating time, amount of intraoperative blood loss, and possible complications were assessed. The intensity of pain was scored on a visual analogue scale. The patients were followed up for 10 days after surgery. Results: There were no statistically significant differences between the demographic and operational characteristics of the patient groups. Statistically significant differences were determined between in the mean intensity of constant and swallowing pain values of group 1 and group 2 or 3, at 4, 8, and 12 hours, and on days 1, 2, 3, and 4, postoperatively. However, no statistical differences were determined between the groups on days 5, 7, and 10. A lower amount of additional analgesic drug was consumed by the ropivacaine group than by the bupivacaine group, and by the bupivacaine group than by the control group, and the differences were statistically significant. Conclusion: Preincisional infiltration of the tonsils with high-dose ropivacaine markedly decreased the intensity of pain after tonsillectomy when compared with bupivacaine or placebo, especially until postoperative day 4 in adults

    Tuberculosis after renal transplantation

    No full text
    WOS: A1996VD46300117PubMed ID: 876925

    Evaluation of in vitro Anticancer Activity of Vulpinic Acid and its Apoptotic Potential Using Gene Expression and Protein Analysis

    No full text
    Derici, Mehmet Kursat/0000-0002-8260-7492; Cansaran-Duman, Demet/0000-0003-3759-6664; Cansaran Duman, Demet/0000-0001-5662-2333WOS: 000450531500011Lichens and their secondary metabolite are still among the many unexamined natural sources in the drug industry. This study was designed to evaluate the cytotoxic effects of vulpinic acid lichen secondary metabolite and 6.25, 12.5, 25, 50, 100, 200 and 400 mu M concentrations that treat cancer cell lines (CaCo2, HepG2, Hep2C, RD Wehi) and normal cells (Vero and L929) by MTT assay. The aim of this study was to determine the apoptotic effect of vulpinic acid on a molecular level. The determination of apoptotic molecular patterns of vulpinic acid was performed on western blot and quantitative real-time PCR (qRT-PCR) analysis. In our study, transcriptome changes on both gene and protein levels showed similar results. The determination of, mRNA levels of Bax, Bcl-2 and P53 genes were showed by qRT-PCR in cancer and normal cell lines. The results of the study showed that IC50 value of vulpinic acid altered the mRNA levels of Bax, Bcl-2 and P53 genes in all examined cancer cells when compared to the untreated cells. When the mRNA levels of the examined genes were compared, it was observed that Box gene showed more expression increase in all cell lines when compared to Bcl-2 and P53 genes. This is the first evaluation of the apoptotic effect of vulpinic acid secondary metabolite on mRNA levels. The current study highlights some points regarding vulpinic acid and its use for cancer treatment.Ankara University Project OfficesAnkara University [16H0415002, 15B0415001]We thank Ankara University Project Offices, Project no. 16H0415002 and Project no. 15B0415001 for the partly financial support
    corecore